Top
The Korea Innovative Medicines Consortium(KIMCo) serves as a collaboration platform for pharmaceutical and biotechnology companies. By promoting open innovation, we consolidate the capabilities of the pharma industry and actively promote collaboration such as co-investment and co-development.
KIMCo promotes private-public collaboration to strengthen the ability to respond to infectious diseases such as COVID-19.
Our goal is to develop innovative medicine for a global market. Therefore, we encourage translational Research for innovative medicines and support cooperation between companies, universities, laboratories, hospitals, and governments.
We carry the pharmaceutical industry for the advancement of drug quality and manufacturing innovation.
The Korea Innovative Medicines Consortium(KIMCo) will strive to promote innovative growth in this industry, secure human rights in public health, and lead Korea to dominate the global pharmaceutical industry. Please continue to show your support and interest.
KIMCo ㅡ Your Platform for Collaboration!
Kyung-Hwa Huh
Representative of KIMCo
